Risk of gastrointestinal complications in cancer patients treated with immune checkpoint inhibitors: a meta-analysis
about
Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trialsRisk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis.Pneumonitis and pneumonitis-related death in cancer patients treated with programmed cell death-1 inhibitors: a systematic review and meta-analysis.Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management.Risk of gastrointestinal toxicities with PD-1 inhibitors in cancer patients: A meta-analysis of randomized clinical trials.Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis.Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors.The Expanding Role of Systemic Therapy in the Management of Hepatocellular Carcinoma
P2860
Q28067583-F8182EE4-F344-47F5-B0EF-7F7216AC14FDQ39947131-49371DED-CA6A-4701-AA07-02966B598E74Q42283210-C0C32DEF-7672-4B6E-AAE8-DF20CA4A9101Q45026631-0A541D50-D5E6-46A1-AC59-4AB528EBC487Q47196610-70ED15BB-D909-4D69-9F42-1595C7B246AFQ52655558-0395C14E-CFE8-4B9B-8C65-8503940A389AQ55314300-B8408E5D-3CFC-4DBE-960A-353894F1C4C7Q58797003-7F72E382-EE04-4D9B-9733-D4527389EFA7
P2860
Risk of gastrointestinal complications in cancer patients treated with immune checkpoint inhibitors: a meta-analysis
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2015
@uk
name
Risk of gastrointestinal compl ...... nt inhibitors: a meta-analysis
@en
Risk of gastrointestinal compl ...... nt inhibitors: a meta-analysis
@nl
type
label
Risk of gastrointestinal compl ...... nt inhibitors: a meta-analysis
@en
Risk of gastrointestinal compl ...... nt inhibitors: a meta-analysis
@nl
prefLabel
Risk of gastrointestinal compl ...... nt inhibitors: a meta-analysis
@en
Risk of gastrointestinal compl ...... nt inhibitors: a meta-analysis
@nl
P356
P1433
P1476
Risk of gastrointestinal compl ...... nt inhibitors: a meta-analysis
@en
P2093
Mona Fouad
P304
P356
10.2217/IMT.15.87
P407
P577
2015-10-29T00:00:00Z